Avation Medical is proud to share that our CEO, Jill Schiaparelli, has been named one of the Top 25 Women Leaders in Consumer Health Tech for 2022 by The Healthcare Technology Report. This year’s awardees lead companies across the healthcare technology industry. What they all have in common is their dedication to driving their companies’ growth and competitiveness in the markets they serve. Please join us in celebrating Jill and all the other accomplished women leaders who received this honor for advancing medical device innovation and patient care. #topwomanleader #femalestrong #medicaldevices #womenleaders #ceo.
About Avation Medical
Avation Medical is an innovative advanced neuromodulation and digital health company pioneering closed-loop, patient-friendly, wearable neuromodulation therapies that deliver personalized therapy based on the patient’s own physiologic response. The Company’s intelligent wearable therapies objectively confirm activation of the target nerve and make neuromodulation technology accessible to millions of patients across a variety of clinical applications by eliminating the need for surgery, needles and permanent implants and shifting therapy into the home environment.
The Company’s wearable bladder therapy and digital health system is available for investigational use only and is not FDA cleared.
Corporate Contact
Jackie Gerberry
Senior Director, Finance
Jgerberry@Avation.com
www.Avation.com
